International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 3 , Pages 692-698 , 1 March 2009

Prediction of Intrafraction Prostate Motion: Accuracy of Pre- and Post-Treatment Imaging and Intermittent Imaging

  • Camille Noel, B.S.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • ,
  • Parag J. Parikh, M.D.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • Corresponding Author InformationReprint requests to: Parag J. Parikh, M.D., Department of Radiation Oncology, Washington University School of Medicine, 4921 Parkview Place, Lower Level, St. Louis, MO 63110. Tel: (314) 362-8525; Fax: (314) 362-8521
    • ,
  • Meghana Roy, B.A.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • ,
  • Patrick Kupelian, M.D.

      Affiliations

    • M.D. Anderson Cancer Center, Orlando, FL
    • ,
  • Arul Mahadevan, M.D.

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Geoffrey Weinstein, M.D.

      Affiliations

    • Sharp Memorial Hospital, San Diego, CA
    • ,
  • Charles Enke, M.D.

      Affiliations

    • Nebraska Medical Center, Omaha, NE
    • ,
  • Nicholas Flores, M.D.

      Affiliations

    • Arizona Oncology Services, Scottsdale, AZ
    • ,
  • David Beyer, M.D.

      Affiliations

    • Nebraska Medical Center, Omaha, NE
    • ,
  • Lisa Levine, Ph.D.

      Affiliations

    • Calypso Medical Technologies, Seattle, WA

Received 19 December 2007 ,Revised 22 April 2008 ,Accepted 25 April 2008.

References 

  1. Cheung R, Tucker SL, Dong L, et al. Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56:1234–1240
  2. Kupelian PA, Mohan DS, Lyons J, et al. Higher than standard radiation doses (≥72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys. 2000;46:567–574
  3. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097–1105
  4. Kupelian PA, Potters L, Khuntia D, et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer. Int J Radiat Oncol Biol Phys. 2004;58:25–33
  5. Pollack A, Hanlon AL, Horwitz EM, et al. Prostate cancer radiotherapy dose response: An update of the Fox Chase experience. J Urol. 2004;171:1132–1136
  6. Hanks GE, Hanlon AL, Epstein B, et al. Dose response in prostate cancer with 8–12 years' follow-up. Int J Radiat Oncol Biol Phys. 2002;54:427–435
  7. Kuban D, Pollack A, Huang E, et al. Hazards of dose escalation in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57:1260–1268
  8. Speight JL, Roach M. Radiotherapy in the management of clinically localized prostate cancer: Evolving standards, consensus, controversies, and new directions. J Clin Oncol. 2005;23:8176–8185
  9. Lock M, Catton C. High-precision radiotherapy: Where are we going and how do we get there?. Can J Urol. 2006;13(Suppl):34–36
  10. Aubry JF, Beaulieu L, Girouard LM, et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys. 2004;60:30–39
  11. Kitamura K, Shirato H, Seppenwoolde Y, et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys. 2002;53:1117–1123
  12. Nederveen AJ, van der Heide UA, Dehnad H, et al. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys. 2002;53:206–214
  13. Trichter F, Ennis RD. Prostate localization using transabdominal ultrasound imaging. Int J Radiat Oncol Biol Phys. 2003;56:1225–1233
  14. Willoughby TR, Kupelian A, Pouliot J, et al. Target localization and real-time tracking using the Calypso 4D Localization System in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;65:528–534
  15. Litzenberg DW, Balter JM, Hadley SW, et al. Influence of intrafraction motion on margins for prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2006;65:548–553
  16. De Crevoisier R, Melancon AD, Kuban DA, et al. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys. 2007;68:1529–1536
  17. Kupelian P, Willoughby T, Mahadevan A, et al. Multi-institutional clinical experience with the Calypso System in localization and continuous real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1088–1098
  18. Kotte AN, Hofman P, Lagendijk JJ, et al. Intrafraction motion of the prostate during external-beam radiation therapy: Analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys. 2007;69:419–425
  19. Huang E, Dong L, Chandra A, et al. Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys. 2002;53:261–268
  20. Cheung P, Sixel K, Morton G, et al. Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer. Int J Radiat Oncol Biol Phys. 2005;62:418–425
  21. Soete G, De Cock M, Verellen D, et al. X-ray-assisted positioning of patients treated by conformal ARC radiotherapy for prostate cancer: Comparison of setup accuracy using implanted markers versus bony structures. Int J Radiat Oncol Biol Phys. 2007;67:823–827
  22. Létourneau D, Martinez AA, Lockman D, et al. Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int J Radiat Oncol Biol Phys. 2005;62:1239–1246
  23. Padhani AR, Khoo VS, Suckling J, et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys. 1999;44:525–533
  24. Mah D, Freedman G, Milestone B, et al. Measurement of intrafractional prostate motion using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2002;54:568–575
  25. Ghilezan MJ, Jaffray DA, Siewerdsen JH, et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys. 2005;62:406–417
  26. Britton KR, Takai Y, Mitsuya M, Nemoto K, Ogawa Y, Yamada S. Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer by a newly developed on-board image-guided system. Radiat Med. 2005;23:14–24
  27. Balter JM, Wright JN, Newell LJ, et al. Accuracy of a wireless localization system for radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61:933–937
  28. Litzenberg DW, Willoughby TR, Balter JM, et al. Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking. Int J Radiat Oncol Biol Phys. 2007;68:1199–1206
  29. Raaijmakers AJ, Raaymakers BW, van der Meer S, Lagendijk JJ. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: Impact of the surface orientation on the entrance and exit dose due to the transverse magnetic field. Phys Med Biol. 2007;52:929–939
  30. Soete G, Arcangeli S, De Meerleer G, et al. Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: Report on acute toxicity. Radiother Oncol. 2006;80:78–81
  31. Koukourakis MI, Touloupidis S, Manavis J, Abatzoglou I, Sismanidou K, Sivridis L. Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: Rationale, technique and early experience. Anticancer Res. 2004;24:3239–3243
  32. Madsen BL, His RA, Pham HT, et al. Intrafractional stability of the prostate using a stereotactic radiotherapy technique. Int J Radiat Oncol Biol Phys. 2003;57:1285–1291
  33. Madsen BL, His RA, Pham HT, et al. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results. Int J Radiat Oncol Biol Phys. 2007;67:1099–1105

 Presented at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Oct 28-Nov 1, 2007, Los Angeles, CA.

 Conflict of interest: Lisa Levine, Ph.D., is an employee of Calypso® Medical Technologies.

PII: S0360-3016(08)00826-2

doi: 10.1016/j.ijrobp.2008.04.076

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 3 , Pages 692-698 , 1 March 2009

Article Tools

* Image Usage & Resolution